https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-10-16 / Oncol Lett 2025 Jan;29(1):6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-10-16 / Oncol Lett 2025 Jan;29(1):62024-10-16 00:00:002024-10-16 00:00:00Anticancer effect of the oncolytic Newcastle disease virus harboring the PTEN gene on glioblastoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-10-10 / BMC Cancer 2024 Oct;24(1):1253
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-10-10 / BMC Cancer 2024 Oct;24(1):12532024-10-10 00:00:002024-10-10 00:00:00Newcastle disease virus enhances the antitumor efficacy of Doxorubicin in a cervical cancer mouse model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-10-09 / Oncoimmunology 2024;13(1):2412876
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-10-09 / Oncoimmunology 2024;13(1):24128762024-10-09 00:00:002024-10-09 00:00:00Trial watch: anticancer vaccination with dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-09-14 / Cureus 2024 Sep;16(9):e69429
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-09-14 / Cureus 2024 Sep;16(9):e694292024-09-14 00:00:002024-09-14 00:00:00Complete Cure of Inoperable Stage IV Locally Advanced Hypopharyngeal Squamous Cell Carcinoma by an Innovative Combination Cancer Immunotherapy Consisting of Radiation, Immune Checkpoint Inhibitors, and Dendritic Cell Vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-09-13 / Oncol Lett 2024 Nov;28(5):550
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-09-13 / Oncol Lett 2024 Nov;28(5):5502024-09-13 00:00:002024-09-13 00:00:00induction of anti‑lung cancer immune response by the A549 lung cancer stem cell lysate‑sensitized dendritic cell vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-09-01 / Anticancer Res 2024 Sep;44(9):3713-3724
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-09-01 / Anticancer Res 2024 Sep;44(9):3713-37242024-09-01 00:00:002024-09-01 00:00:00Personalized Dendritic-cell-based Vaccines Targeting Cancer Neoantigens
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-08-30 / Front Mol Biosci 2024;11:1331369
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-08-30 / Front Mol Biosci 2024;11:13313692024-08-30 00:00:002024-08-30 00:00:00Antimetastatic and antitumor activities of oncolytic NDV AMHA1 in a 3D culture model of breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-08-14 / PLoS One 2024;19(8):e0308599
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-08-14 / PLoS One 2024;19(8):e03085992024-08-14 00:00:002024-08-14 00:00:00Synergistic cytotoxicity of olive leaf extract-loaded lipid nanocarriers combined with Newcastle disease virus against cervical cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-07-20 / Cureus 2024 Jul;16(7):e64972
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-07-20 / Cureus 2024 Jul;16(7):e649722024-07-20 00:00:002024-07-20 00:00:00Combination of Radiation Therapy, Wim’s Tumor 1 (WT1) Dendritic Cell Vaccine Therapy, and α-Galactosylceramide-Pulsed Dendritic Cell Vaccine Therapy for End-Stage Small Bowel Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-07-05 / Biomedicines 2024 Jul;12(7)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-07-05 / Biomedicines 2024 Jul;12(7)2024-07-05 00:00:002024-07-05 00:00:00Newcastle Disease Virus Virotherapy: Unveiling Oncolytic Efficacy and Immunomodulation
